Plasma exosomes impair microglial degradation of α‐synuclein through V‐ATPase subunit V1G1
Introduction Microglia are the main phagocytes in the brain and can induce neuroinflammation. Moreover, they are critical to alpha‐synuclein (α‐syn) aggregation and propagation. Plasma exosomes derived from patients diagnosed with Parkinson's disease (PD‐exo) reportedly evoked α‐syn aggregation...
Gespeichert in:
Veröffentlicht in: | CNS neuroscience & therapeutics 2024-05, Vol.30 (5), p.e14738-n/a |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 5 |
container_start_page | e14738 |
container_title | CNS neuroscience & therapeutics |
container_volume | 30 |
creator | Li, Yunna Wang, Yiming Kou, Liang Yin, Sijia Chi, Xiaosa Sun, Yadi Wu, Jiawei Jin, Zongjie Zhou, Qiulu Zou, Wenkai Wang, Tao Xia, Yun |
description | Introduction
Microglia are the main phagocytes in the brain and can induce neuroinflammation. Moreover, they are critical to alpha‐synuclein (α‐syn) aggregation and propagation. Plasma exosomes derived from patients diagnosed with Parkinson's disease (PD‐exo) reportedly evoked α‐syn aggregation and inflammation in microglia. In turn, microglia internalized and released exosomal α‐syn, enhancing α‐syn propagation. However, the specific mechanism through which PD‐exo influences α‐syn degradation remains unknown.
Methods
Exosomes were extracted from the plasma of patients with PD by differential ultracentrifugation, analyzed using electron microscopy (EM) and nanoparticle flow cytometry, and stereotaxically injected into the unilateral striatum of the mice. Transmission EM was employed to visualize lysosomes and autophagosomes in BV2 cells, and lysosome pH was measured with LysoSensor Yellow/Blue DND‐160. Cathepsin B and D, lysosomal‐associated membrane protein 1 (LAMP1), ATP6V1G1, tumor susceptibility gene 101 protein, calnexin, α‐syn, ionized calcium binding adaptor molecule 1, and NLR family pyrin domain containing 3 were evaluated using quantitative polymerase chain reaction or western blotting, and α‐syn, LAMP1, and ATP6V1G1 were also observed by immunofluorescence. Small interfering ribonucleic acid against V1G1 was transfected into BV2 cells and primary microglia using Lipofectamine® 3000. A PD mouse model was established via injection with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) into mice. A lentiviral‐mediated strategy to overexpress ATP6V1G1 in the brain of MPTP‐treated mice was employed. Motor coordination was assessed using rotarod and pole tests, and neurodegeneration in the mouse substantia nigra and striatum tissues was determined using immunofluorescence histochemical and western blotting of tyrosine hydroxylase.
Results
PD‐exo decreased the expression of V1G1, responsible for the acidification of intra‐ and extracellular milieu. This impairment of lysosomal acidification resulted in the accumulation of abnormally swollen lysosomes and decreased lysosomal enzyme activities, impairing lysosomal protein degradation and causing α‐syn accumulation. Additionally, V1G1 overexpression conferred the mice neuroprotection during MPTP exposure.
Conclusion
Pathogenic protein accumulation is a key feature of PD, and compromised V‐type ATPase dysfunction might participate in PD pathogenesis. Moreover, V1G1 overexpression protects against neurona |
doi_str_mv | 10.1111/cns.14738 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3050941885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A800447868</galeid><sourcerecordid>A800447868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4158-a71ce3f3bd95e6fe6867c4bca824c7a53321bcf3a7125db76c5d8144426623d83</originalsourceid><addsrcrecordid>eNp1kU1uFDEQhS0EIiGw4ALIEhtYzMRu__ZyNIIQKQqRCNlabnf1xFG3PdjdCrPLEXIVLsIhOEmcdMgCCXvhUunzq6d6CL2lZEnLOXQhLylXTD9D-1QJsRA1r58_1YzsoVc5XxEiK13rl2iPaUWqmrF9ZM56mweL4WfMcYCM_bC1PuHBuxQ3vbc9bmGTbGtHHwOOHf7968_Nbd6FyfXgAx4vU5w2l_iidFfnZzYDzlMzBT_iC3pEX6MXne0zvHl8D9D3z5_O118WJ1-Pjterk4XjVOiFVdQB61jT1gJkB1JL5XjjrK64U1YwVtHGdaxwlWgbJZ1oNeWcV1JWrNXsAH2Ydbcp_pggj2bw2UHf2wBxyoYRQWpOtRYFff8PehWnFIq7QkmiKi20KtRypja2B-NDF8dkXbktlN3EAJ0v_ZUmhHOl5b2Dj_OHsricE3Rmm_xg085QYu5jMiUm8xBTYd89WpiaAdon8m8uBTicgesyZfd_JbM-_TZL3gHa_J2R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3060728587</pqid></control><display><type>article</type><title>Plasma exosomes impair microglial degradation of α‐synuclein through V‐ATPase subunit V1G1</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Li, Yunna ; Wang, Yiming ; Kou, Liang ; Yin, Sijia ; Chi, Xiaosa ; Sun, Yadi ; Wu, Jiawei ; Jin, Zongjie ; Zhou, Qiulu ; Zou, Wenkai ; Wang, Tao ; Xia, Yun</creator><creatorcontrib>Li, Yunna ; Wang, Yiming ; Kou, Liang ; Yin, Sijia ; Chi, Xiaosa ; Sun, Yadi ; Wu, Jiawei ; Jin, Zongjie ; Zhou, Qiulu ; Zou, Wenkai ; Wang, Tao ; Xia, Yun</creatorcontrib><description>Introduction
Microglia are the main phagocytes in the brain and can induce neuroinflammation. Moreover, they are critical to alpha‐synuclein (α‐syn) aggregation and propagation. Plasma exosomes derived from patients diagnosed with Parkinson's disease (PD‐exo) reportedly evoked α‐syn aggregation and inflammation in microglia. In turn, microglia internalized and released exosomal α‐syn, enhancing α‐syn propagation. However, the specific mechanism through which PD‐exo influences α‐syn degradation remains unknown.
Methods
Exosomes were extracted from the plasma of patients with PD by differential ultracentrifugation, analyzed using electron microscopy (EM) and nanoparticle flow cytometry, and stereotaxically injected into the unilateral striatum of the mice. Transmission EM was employed to visualize lysosomes and autophagosomes in BV2 cells, and lysosome pH was measured with LysoSensor Yellow/Blue DND‐160. Cathepsin B and D, lysosomal‐associated membrane protein 1 (LAMP1), ATP6V1G1, tumor susceptibility gene 101 protein, calnexin, α‐syn, ionized calcium binding adaptor molecule 1, and NLR family pyrin domain containing 3 were evaluated using quantitative polymerase chain reaction or western blotting, and α‐syn, LAMP1, and ATP6V1G1 were also observed by immunofluorescence. Small interfering ribonucleic acid against V1G1 was transfected into BV2 cells and primary microglia using Lipofectamine® 3000. A PD mouse model was established via injection with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) into mice. A lentiviral‐mediated strategy to overexpress ATP6V1G1 in the brain of MPTP‐treated mice was employed. Motor coordination was assessed using rotarod and pole tests, and neurodegeneration in the mouse substantia nigra and striatum tissues was determined using immunofluorescence histochemical and western blotting of tyrosine hydroxylase.
Results
PD‐exo decreased the expression of V1G1, responsible for the acidification of intra‐ and extracellular milieu. This impairment of lysosomal acidification resulted in the accumulation of abnormally swollen lysosomes and decreased lysosomal enzyme activities, impairing lysosomal protein degradation and causing α‐syn accumulation. Additionally, V1G1 overexpression conferred the mice neuroprotection during MPTP exposure.
Conclusion
Pathogenic protein accumulation is a key feature of PD, and compromised V‐type ATPase dysfunction might participate in PD pathogenesis. Moreover, V1G1 overexpression protects against neuronal toxicity in an MPTP‐based PD mouse model, which may provide opportunities to develop novel therapeutic interventions for PD treatment.
Plasma‐derived exosomes from patients with PD contain toxic α‐syn and PD‐exo downregulates lysosomal V1G1 expression; PD‐exo alternated the amount, morphology, and distribution of lysosomes in microglia and impaired the activity of hydrolytic enzymes in the lumen; PD‐exo augmented the accumulation of pathological α‐syn within microglia and induced NLRP3‐mediated neuroinflammation; and V1G1 deficiency impaired lysosomal function, leading to further aggregation of α‐syn in microglia and inflammation.</description><identifier>ISSN: 1755-5930</identifier><identifier>EISSN: 1755-5949</identifier><identifier>DOI: 10.1111/cns.14738</identifier><identifier>PMID: 38702933</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Acidification ; Adenosine triphosphatase ; Aged ; alpha-Synuclein - metabolism ; Alzheimer's disease ; Animals ; Antibodies ; Calnexin ; Cathepsin B ; Cathepsins ; Degradation ; Disease ; Disease susceptibility ; Electron microscopy ; Enzymatic activity ; exosome ; Exosomes ; Exosomes - metabolism ; Female ; Flow cytometry ; H+-transporting ATPase ; Health aspects ; Humans ; Immunofluorescence ; Inflammation ; LAMP-1 protein ; Lysosomal protein ; lysosome ; Lysosomes ; Lysosomes - metabolism ; Male ; Membrane proteins ; Mice ; Mice, Inbred C57BL ; Microglia ; Microglia - metabolism ; Microglia - pathology ; Middle Aged ; Movement disorders ; MPTP ; Nanoparticles ; Neostriatum ; Neurodegeneration ; Neurodegenerative diseases ; Neurons ; Parkinson Disease - metabolism ; Parkinson Disease - pathology ; Parkinson's disease ; Phagocytes ; Plasma ; Proteolysis ; RNA ; Transmission electron microscopy ; Tyrosine ; Vacuolar Proton-Translocating ATPases - genetics ; Vacuolar Proton-Translocating ATPases - metabolism ; V‐ATPase ; Western blotting ; α‐synuclein</subject><ispartof>CNS neuroscience & therapeutics, 2024-05, Vol.30 (5), p.e14738-n/a</ispartof><rights>2024 The Authors. published by John Wiley & Sons Ltd.</rights><rights>2024 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.</rights><rights>COPYRIGHT 2024 John Wiley & Sons, Inc.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4158-a71ce3f3bd95e6fe6867c4bca824c7a53321bcf3a7125db76c5d8144426623d83</cites><orcidid>0000-0002-8715-7064 ; 0000-0003-3313-629X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcns.14738$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcns.14738$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,860,1411,11541,27901,27902,45550,45551,46027,46451</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38702933$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Yunna</creatorcontrib><creatorcontrib>Wang, Yiming</creatorcontrib><creatorcontrib>Kou, Liang</creatorcontrib><creatorcontrib>Yin, Sijia</creatorcontrib><creatorcontrib>Chi, Xiaosa</creatorcontrib><creatorcontrib>Sun, Yadi</creatorcontrib><creatorcontrib>Wu, Jiawei</creatorcontrib><creatorcontrib>Jin, Zongjie</creatorcontrib><creatorcontrib>Zhou, Qiulu</creatorcontrib><creatorcontrib>Zou, Wenkai</creatorcontrib><creatorcontrib>Wang, Tao</creatorcontrib><creatorcontrib>Xia, Yun</creatorcontrib><title>Plasma exosomes impair microglial degradation of α‐synuclein through V‐ATPase subunit V1G1</title><title>CNS neuroscience & therapeutics</title><addtitle>CNS Neurosci Ther</addtitle><description>Introduction
Microglia are the main phagocytes in the brain and can induce neuroinflammation. Moreover, they are critical to alpha‐synuclein (α‐syn) aggregation and propagation. Plasma exosomes derived from patients diagnosed with Parkinson's disease (PD‐exo) reportedly evoked α‐syn aggregation and inflammation in microglia. In turn, microglia internalized and released exosomal α‐syn, enhancing α‐syn propagation. However, the specific mechanism through which PD‐exo influences α‐syn degradation remains unknown.
Methods
Exosomes were extracted from the plasma of patients with PD by differential ultracentrifugation, analyzed using electron microscopy (EM) and nanoparticle flow cytometry, and stereotaxically injected into the unilateral striatum of the mice. Transmission EM was employed to visualize lysosomes and autophagosomes in BV2 cells, and lysosome pH was measured with LysoSensor Yellow/Blue DND‐160. Cathepsin B and D, lysosomal‐associated membrane protein 1 (LAMP1), ATP6V1G1, tumor susceptibility gene 101 protein, calnexin, α‐syn, ionized calcium binding adaptor molecule 1, and NLR family pyrin domain containing 3 were evaluated using quantitative polymerase chain reaction or western blotting, and α‐syn, LAMP1, and ATP6V1G1 were also observed by immunofluorescence. Small interfering ribonucleic acid against V1G1 was transfected into BV2 cells and primary microglia using Lipofectamine® 3000. A PD mouse model was established via injection with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) into mice. A lentiviral‐mediated strategy to overexpress ATP6V1G1 in the brain of MPTP‐treated mice was employed. Motor coordination was assessed using rotarod and pole tests, and neurodegeneration in the mouse substantia nigra and striatum tissues was determined using immunofluorescence histochemical and western blotting of tyrosine hydroxylase.
Results
PD‐exo decreased the expression of V1G1, responsible for the acidification of intra‐ and extracellular milieu. This impairment of lysosomal acidification resulted in the accumulation of abnormally swollen lysosomes and decreased lysosomal enzyme activities, impairing lysosomal protein degradation and causing α‐syn accumulation. Additionally, V1G1 overexpression conferred the mice neuroprotection during MPTP exposure.
Conclusion
Pathogenic protein accumulation is a key feature of PD, and compromised V‐type ATPase dysfunction might participate in PD pathogenesis. Moreover, V1G1 overexpression protects against neuronal toxicity in an MPTP‐based PD mouse model, which may provide opportunities to develop novel therapeutic interventions for PD treatment.
Plasma‐derived exosomes from patients with PD contain toxic α‐syn and PD‐exo downregulates lysosomal V1G1 expression; PD‐exo alternated the amount, morphology, and distribution of lysosomes in microglia and impaired the activity of hydrolytic enzymes in the lumen; PD‐exo augmented the accumulation of pathological α‐syn within microglia and induced NLRP3‐mediated neuroinflammation; and V1G1 deficiency impaired lysosomal function, leading to further aggregation of α‐syn in microglia and inflammation.</description><subject>Acidification</subject><subject>Adenosine triphosphatase</subject><subject>Aged</subject><subject>alpha-Synuclein - metabolism</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Calnexin</subject><subject>Cathepsin B</subject><subject>Cathepsins</subject><subject>Degradation</subject><subject>Disease</subject><subject>Disease susceptibility</subject><subject>Electron microscopy</subject><subject>Enzymatic activity</subject><subject>exosome</subject><subject>Exosomes</subject><subject>Exosomes - metabolism</subject><subject>Female</subject><subject>Flow cytometry</subject><subject>H+-transporting ATPase</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immunofluorescence</subject><subject>Inflammation</subject><subject>LAMP-1 protein</subject><subject>Lysosomal protein</subject><subject>lysosome</subject><subject>Lysosomes</subject><subject>Lysosomes - metabolism</subject><subject>Male</subject><subject>Membrane proteins</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microglia</subject><subject>Microglia - metabolism</subject><subject>Microglia - pathology</subject><subject>Middle Aged</subject><subject>Movement disorders</subject><subject>MPTP</subject><subject>Nanoparticles</subject><subject>Neostriatum</subject><subject>Neurodegeneration</subject><subject>Neurodegenerative diseases</subject><subject>Neurons</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson's disease</subject><subject>Phagocytes</subject><subject>Plasma</subject><subject>Proteolysis</subject><subject>RNA</subject><subject>Transmission electron microscopy</subject><subject>Tyrosine</subject><subject>Vacuolar Proton-Translocating ATPases - genetics</subject><subject>Vacuolar Proton-Translocating ATPases - metabolism</subject><subject>V‐ATPase</subject><subject>Western blotting</subject><subject>α‐synuclein</subject><issn>1755-5930</issn><issn>1755-5949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU1uFDEQhS0EIiGw4ALIEhtYzMRu__ZyNIIQKQqRCNlabnf1xFG3PdjdCrPLEXIVLsIhOEmcdMgCCXvhUunzq6d6CL2lZEnLOXQhLylXTD9D-1QJsRA1r58_1YzsoVc5XxEiK13rl2iPaUWqmrF9ZM56mweL4WfMcYCM_bC1PuHBuxQ3vbc9bmGTbGtHHwOOHf7968_Nbd6FyfXgAx4vU5w2l_iidFfnZzYDzlMzBT_iC3pEX6MXne0zvHl8D9D3z5_O118WJ1-Pjterk4XjVOiFVdQB61jT1gJkB1JL5XjjrK64U1YwVtHGdaxwlWgbJZ1oNeWcV1JWrNXsAH2Ydbcp_pggj2bw2UHf2wBxyoYRQWpOtRYFff8PehWnFIq7QkmiKi20KtRypja2B-NDF8dkXbktlN3EAJ0v_ZUmhHOl5b2Dj_OHsricE3Rmm_xg085QYu5jMiUm8xBTYd89WpiaAdon8m8uBTicgesyZfd_JbM-_TZL3gHa_J2R</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Li, Yunna</creator><creator>Wang, Yiming</creator><creator>Kou, Liang</creator><creator>Yin, Sijia</creator><creator>Chi, Xiaosa</creator><creator>Sun, Yadi</creator><creator>Wu, Jiawei</creator><creator>Jin, Zongjie</creator><creator>Zhou, Qiulu</creator><creator>Zou, Wenkai</creator><creator>Wang, Tao</creator><creator>Xia, Yun</creator><general>John Wiley & Sons, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8715-7064</orcidid><orcidid>https://orcid.org/0000-0003-3313-629X</orcidid></search><sort><creationdate>202405</creationdate><title>Plasma exosomes impair microglial degradation of α‐synuclein through V‐ATPase subunit V1G1</title><author>Li, Yunna ; Wang, Yiming ; Kou, Liang ; Yin, Sijia ; Chi, Xiaosa ; Sun, Yadi ; Wu, Jiawei ; Jin, Zongjie ; Zhou, Qiulu ; Zou, Wenkai ; Wang, Tao ; Xia, Yun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4158-a71ce3f3bd95e6fe6867c4bca824c7a53321bcf3a7125db76c5d8144426623d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acidification</topic><topic>Adenosine triphosphatase</topic><topic>Aged</topic><topic>alpha-Synuclein - metabolism</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Calnexin</topic><topic>Cathepsin B</topic><topic>Cathepsins</topic><topic>Degradation</topic><topic>Disease</topic><topic>Disease susceptibility</topic><topic>Electron microscopy</topic><topic>Enzymatic activity</topic><topic>exosome</topic><topic>Exosomes</topic><topic>Exosomes - metabolism</topic><topic>Female</topic><topic>Flow cytometry</topic><topic>H+-transporting ATPase</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immunofluorescence</topic><topic>Inflammation</topic><topic>LAMP-1 protein</topic><topic>Lysosomal protein</topic><topic>lysosome</topic><topic>Lysosomes</topic><topic>Lysosomes - metabolism</topic><topic>Male</topic><topic>Membrane proteins</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microglia</topic><topic>Microglia - metabolism</topic><topic>Microglia - pathology</topic><topic>Middle Aged</topic><topic>Movement disorders</topic><topic>MPTP</topic><topic>Nanoparticles</topic><topic>Neostriatum</topic><topic>Neurodegeneration</topic><topic>Neurodegenerative diseases</topic><topic>Neurons</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson's disease</topic><topic>Phagocytes</topic><topic>Plasma</topic><topic>Proteolysis</topic><topic>RNA</topic><topic>Transmission electron microscopy</topic><topic>Tyrosine</topic><topic>Vacuolar Proton-Translocating ATPases - genetics</topic><topic>Vacuolar Proton-Translocating ATPases - metabolism</topic><topic>V‐ATPase</topic><topic>Western blotting</topic><topic>α‐synuclein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Yunna</creatorcontrib><creatorcontrib>Wang, Yiming</creatorcontrib><creatorcontrib>Kou, Liang</creatorcontrib><creatorcontrib>Yin, Sijia</creatorcontrib><creatorcontrib>Chi, Xiaosa</creatorcontrib><creatorcontrib>Sun, Yadi</creatorcontrib><creatorcontrib>Wu, Jiawei</creatorcontrib><creatorcontrib>Jin, Zongjie</creatorcontrib><creatorcontrib>Zhou, Qiulu</creatorcontrib><creatorcontrib>Zou, Wenkai</creatorcontrib><creatorcontrib>Wang, Tao</creatorcontrib><creatorcontrib>Xia, Yun</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>CNS neuroscience & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Yunna</au><au>Wang, Yiming</au><au>Kou, Liang</au><au>Yin, Sijia</au><au>Chi, Xiaosa</au><au>Sun, Yadi</au><au>Wu, Jiawei</au><au>Jin, Zongjie</au><au>Zhou, Qiulu</au><au>Zou, Wenkai</au><au>Wang, Tao</au><au>Xia, Yun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma exosomes impair microglial degradation of α‐synuclein through V‐ATPase subunit V1G1</atitle><jtitle>CNS neuroscience & therapeutics</jtitle><addtitle>CNS Neurosci Ther</addtitle><date>2024-05</date><risdate>2024</risdate><volume>30</volume><issue>5</issue><spage>e14738</spage><epage>n/a</epage><pages>e14738-n/a</pages><issn>1755-5930</issn><eissn>1755-5949</eissn><abstract>Introduction
Microglia are the main phagocytes in the brain and can induce neuroinflammation. Moreover, they are critical to alpha‐synuclein (α‐syn) aggregation and propagation. Plasma exosomes derived from patients diagnosed with Parkinson's disease (PD‐exo) reportedly evoked α‐syn aggregation and inflammation in microglia. In turn, microglia internalized and released exosomal α‐syn, enhancing α‐syn propagation. However, the specific mechanism through which PD‐exo influences α‐syn degradation remains unknown.
Methods
Exosomes were extracted from the plasma of patients with PD by differential ultracentrifugation, analyzed using electron microscopy (EM) and nanoparticle flow cytometry, and stereotaxically injected into the unilateral striatum of the mice. Transmission EM was employed to visualize lysosomes and autophagosomes in BV2 cells, and lysosome pH was measured with LysoSensor Yellow/Blue DND‐160. Cathepsin B and D, lysosomal‐associated membrane protein 1 (LAMP1), ATP6V1G1, tumor susceptibility gene 101 protein, calnexin, α‐syn, ionized calcium binding adaptor molecule 1, and NLR family pyrin domain containing 3 were evaluated using quantitative polymerase chain reaction or western blotting, and α‐syn, LAMP1, and ATP6V1G1 were also observed by immunofluorescence. Small interfering ribonucleic acid against V1G1 was transfected into BV2 cells and primary microglia using Lipofectamine® 3000. A PD mouse model was established via injection with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) into mice. A lentiviral‐mediated strategy to overexpress ATP6V1G1 in the brain of MPTP‐treated mice was employed. Motor coordination was assessed using rotarod and pole tests, and neurodegeneration in the mouse substantia nigra and striatum tissues was determined using immunofluorescence histochemical and western blotting of tyrosine hydroxylase.
Results
PD‐exo decreased the expression of V1G1, responsible for the acidification of intra‐ and extracellular milieu. This impairment of lysosomal acidification resulted in the accumulation of abnormally swollen lysosomes and decreased lysosomal enzyme activities, impairing lysosomal protein degradation and causing α‐syn accumulation. Additionally, V1G1 overexpression conferred the mice neuroprotection during MPTP exposure.
Conclusion
Pathogenic protein accumulation is a key feature of PD, and compromised V‐type ATPase dysfunction might participate in PD pathogenesis. Moreover, V1G1 overexpression protects against neuronal toxicity in an MPTP‐based PD mouse model, which may provide opportunities to develop novel therapeutic interventions for PD treatment.
Plasma‐derived exosomes from patients with PD contain toxic α‐syn and PD‐exo downregulates lysosomal V1G1 expression; PD‐exo alternated the amount, morphology, and distribution of lysosomes in microglia and impaired the activity of hydrolytic enzymes in the lumen; PD‐exo augmented the accumulation of pathological α‐syn within microglia and induced NLRP3‐mediated neuroinflammation; and V1G1 deficiency impaired lysosomal function, leading to further aggregation of α‐syn in microglia and inflammation.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>38702933</pmid><doi>10.1111/cns.14738</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-8715-7064</orcidid><orcidid>https://orcid.org/0000-0003-3313-629X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1755-5930 |
ispartof | CNS neuroscience & therapeutics, 2024-05, Vol.30 (5), p.e14738-n/a |
issn | 1755-5930 1755-5949 |
language | eng |
recordid | cdi_proquest_miscellaneous_3050941885 |
source | MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Acidification Adenosine triphosphatase Aged alpha-Synuclein - metabolism Alzheimer's disease Animals Antibodies Calnexin Cathepsin B Cathepsins Degradation Disease Disease susceptibility Electron microscopy Enzymatic activity exosome Exosomes Exosomes - metabolism Female Flow cytometry H+-transporting ATPase Health aspects Humans Immunofluorescence Inflammation LAMP-1 protein Lysosomal protein lysosome Lysosomes Lysosomes - metabolism Male Membrane proteins Mice Mice, Inbred C57BL Microglia Microglia - metabolism Microglia - pathology Middle Aged Movement disorders MPTP Nanoparticles Neostriatum Neurodegeneration Neurodegenerative diseases Neurons Parkinson Disease - metabolism Parkinson Disease - pathology Parkinson's disease Phagocytes Plasma Proteolysis RNA Transmission electron microscopy Tyrosine Vacuolar Proton-Translocating ATPases - genetics Vacuolar Proton-Translocating ATPases - metabolism V‐ATPase Western blotting α‐synuclein |
title | Plasma exosomes impair microglial degradation of α‐synuclein through V‐ATPase subunit V1G1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A05%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20exosomes%20impair%20microglial%20degradation%20of%20%CE%B1%E2%80%90synuclein%20through%20V%E2%80%90ATPase%20subunit%20V1G1&rft.jtitle=CNS%20neuroscience%20&%20therapeutics&rft.au=Li,%20Yunna&rft.date=2024-05&rft.volume=30&rft.issue=5&rft.spage=e14738&rft.epage=n/a&rft.pages=e14738-n/a&rft.issn=1755-5930&rft.eissn=1755-5949&rft_id=info:doi/10.1111/cns.14738&rft_dat=%3Cgale_proqu%3EA800447868%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3060728587&rft_id=info:pmid/38702933&rft_galeid=A800447868&rfr_iscdi=true |